Mineralys Therapeutics, Inc. (MLYS) Corporate Subsidiaries
Mineralys Therapeutics, Inc. (MLYS) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MLYS
CIK: 1933414
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerRachelle Moulton
Audit LocationDenver, Colorado, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-10-13 | — | 144 Filing | 0001964306-26-000466 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001933414-26-000121 | View SEC Doc Filr Page |
| 144 | 2026-09-30 | — | 144 Filing | 0001964306-26-000459 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | FORM 4 | 0001963901-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-21 | FORM 4 | 0001916048-26-000014 | View SEC Doc Filr Page |
| 144 | 2026-09-22 | — | 144 Filing | 0001950047-26-009734 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001964306-26-000453 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0001816952-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-09-17 | — | 144 Filing | 0001964306-26-000448 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001964306-26-000445 | View SEC Doc Filr Page |
| 144 | 2026-09-14 | — | 144 Filing | 0001964306-26-000440 | View SEC Doc Filr Page |
| 144 | 2026-09-09 | — | 144 Filing | 0001964306-26-000434 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001916048-26-000012 | View SEC Doc Filr Page |
| 144 | 2026-08-21 | — | 144 Filing | 0001964306-26-000406 | View SEC Doc Filr Page |
| 144 | 2026-08-17 | — | 144 Filing | 0001964306-26-000390 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001964306-26-000385 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001933414-26-000120 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-08-10 | FORM 3 | 0001933414-26-000119 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001933414-26-000118 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001933414-26-000114 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-05 | 8-K | 0001933414-26-000112 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001964306-26-000377 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002085 | View SEC Doc Filr Page |
| 4 | 2026-07-23 | 2026-07-21 | FORM 4 | 0001916048-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-07-21 | — | 144 Filing | 0001964306-26-000324 | View SEC Doc Filr Page |